Tracing the evolutionary history of hepadnaviruses in terms of e antigen and middle envelope protein expression or processing.


Journal

Virus research
ISSN: 1872-7492
Titre abrégé: Virus Res
Pays: Netherlands
ID NLM: 8410979

Informations de publication

Date de publication:
15 01 2020
Historique:
received: 26 09 2019
revised: 25 11 2019
accepted: 26 11 2019
pubmed: 1 12 2019
medline: 18 11 2020
entrez: 1 12 2019
Statut: ppublish

Résumé

Hepatitis B virus (HBV) is the prototype of hepadnaviruses, which can be subgrouped into orthohepadnaviruses infecting mammals, avihehepadnaviruses of birds, metahepadnaviruses of fish, and herpetohepadnaviruses of amphibians and reptiles. The middle (M) envelope protein and e antigen are new additions in the evolution of hepadnaviruses. They are alternative translation products of the transcripts for small (S) envelope and core proteins, respectively. For HBV, e antigen is converted from precore/core protein by removal of N-terminal signal peptide followed by furin-mediated cleavage of the basic C-terminus. This study compared old and newly discovered hepadnaviruses for their envelope protein and e antigen expression or processing. The S protein of bat hepatitis B virus (BHBV) and two metahepadnaviruses is probably myristoylated, in addition to two avihepadnaviruses. While most orthohepadnaviruses express a functional M protein with N-linked glycosylation near the amino-terminus, most metahepadnaviruses and herpetohepadnaviruses probably do not. These viruses and one orthohepadnavirus, the shrew hepatitis B virus, lack an open precore region required for e antigen expression. Potential furin cleavage sites (RXXR sequence) can be found in e antigen precursors of orthohepadnaviruses and avihepadnaviruses. Despite much larger precore/core proteins of avihepadnaviruses and their limited sequence homology with those of orthohepadnaviruses, their proximal RXXR motif can be aligned with a distal RXXR motif for orthohepadnaviruses. Thus, furin or another basic endopeptidase is probably the shared enzyme for hepadnaviral e antigen maturation. A precore-derived cysteine residue is involved in forming intramolecular disulfide bond of HBV e antigen to prevent particle formation, and such a cysteine residue is conserved for both orthohepadnaviruses and avihepadnaviruses. All orthohepadnaviruses have an X gene, while all avihepadnaviruses can express the e antigen. M protein expression appears to be the most recent event in the evolution of hepadnaviruses.

Identifiants

pubmed: 31785305
pii: S0168-1702(19)30696-3
doi: 10.1016/j.virusres.2019.197825
pmc: PMC6942179
mid: NIHMS1545986
pii:
doi:

Substances chimiques

Antigens, Viral 0
Hepatitis B e Antigens 0
Viral Envelope Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

197825

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI116639
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI142456
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16151-6
pubmed: 24043818
J Virol. 1989 Feb;63(2):798-808
pubmed: 2463383
Clin Mol Hepatol. 2015 Sep;21(3):193-9
pubmed: 26523264
Arch Virol. 2012 Mar;157(3):585-90
pubmed: 22183110
J Virol. 1990 Mar;64(3):1298-303
pubmed: 2304145
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6599-603
pubmed: 2395863
J Virol. 1987 Oct;61(10):3322-5
pubmed: 3041052
J Virol. 1991 Jul;65(7):3489-95
pubmed: 2041077
Lancet. 1989 Sep 9;2(8663):588-91
pubmed: 2570285
Cell Host Microbe. 2017 Sep 13;22(3):387-399.e6
pubmed: 28867387
J Virol. 1992 Sep;66(9):5682-4
pubmed: 1501300
J Virol. 2001 Feb;75(4):1968-77
pubmed: 11160696
Cell. 1982 Jun;29(2):403-15
pubmed: 6180831
Virology. 1991 Mar;181(1):359-63
pubmed: 1994583
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5757-61
pubmed: 9576957
Virology. 2018 Jan 15;514:88-97
pubmed: 29153861
Virology. 2019 May;531:162-170
pubmed: 30884426
Virology. 1996 Apr 15;218(2):396-9
pubmed: 8610467
J Cell Biol. 1988 Apr;106(4):1093-104
pubmed: 3283145
J Virol. 2009 Apr;83(8):3507-17
pubmed: 19193799
Proc Natl Acad Sci U S A. 1980 May;77(5):2941-5
pubmed: 6930677
Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):17007-17012
pubmed: 31371507
Virology. 1993 May;194(1):137-48
pubmed: 8480417
J Biol Chem. 2003 Jan 10;278(2):891-5
pubmed: 12417589
Hepatology. 2003 Nov;38(5):1075-86
pubmed: 14578844
Viruses. 2018 May 17;10(5):
pubmed: 29772771
J Virol. 1990 Dec;64(12):6141-7
pubmed: 2243390
Virology. 2001 Oct 10;289(1):114-28
pubmed: 11601923
J Immunol. 1972 Nov;109(5):1017-21
pubmed: 4116763
J Virol. 1980 Dec;36(3):829-36
pubmed: 7463557
Virology. 1995 Nov 10;213(2):292-9
pubmed: 7491754
Sci Rep. 2019 Jul 23;9(1):10668
pubmed: 31337847
Arch Virol. 2015 Jan;160(1):335-7
pubmed: 25193071
Elife. 2012 Nov 13;1:e00049
pubmed: 23150796
J Virol. 2009 Nov;83(21):11152-65
pubmed: 19706705
J Virol. 2015 Dec;89(23):11801-11
pubmed: 26378165
Virology. 2015 May;479-480:672-86
pubmed: 25759099
J Virol. 1993 Sep;67(9):5402-10
pubmed: 8350403
J Virol. 2005 Mar;79(5):2729-42
pubmed: 15708992
J Virol. 1993 Jul;67(7):4307-15
pubmed: 8510224
Virology. 1990 Jun;176(2):596-603
pubmed: 2345966
Proc Natl Acad Sci U S A. 1988 Nov;85(22):8405-9
pubmed: 3186731
Virology. 1999 Sep 15;262(1):39-54
pubmed: 10489339
Emerg Infect Dis. 2013 Apr;19(4):638-40
pubmed: 23631923
Virology. 1991 Apr;181(2):733-7
pubmed: 2014646
J Immunol. 1983 Jun;130(6):2903-7
pubmed: 6189903
Virol J. 2017 Feb 22;14(1):40
pubmed: 28222808
J Hepatol. 2018 Jun;68(6):1114-1122
pubmed: 29428874
Proc Natl Acad Sci U S A. 1978 Sep;75(9):4533-7
pubmed: 212758
J Virol. 1993 Mar;67(3):1315-21
pubmed: 8437217
J Virol. 1993 Sep;67(9):5651-5
pubmed: 8350418
J Virol. 2010 Apr;84(8):3879-88
pubmed: 20130049
Emerg Microbes Infect. 2013 Sep;2(9):e56
pubmed: 26038488
N Engl J Med. 2004 Mar 11;350(11):1118-29
pubmed: 15014185
J Virol. 2016 Aug 12;90(17):7920-33
pubmed: 27334580
J Hepatol. 1991;13 Suppl 4:S68-73
pubmed: 1668333
J Virol. 1987 Dec;61(12):3701-9
pubmed: 3682059
J Virol. 1988 Oct;62(10):3832-9
pubmed: 3418788
Hepatology. 2000 Jan;31(1):190-200
pubmed: 10613745

Auteurs

Qianru Wang (Q)

Department of Pathobiology, Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Yanli Qin (Y)

Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.

Jing Zhang (J)

Department of Pathobiology, Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Lucy Jia (L)

Liver Research Center, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, RI, USA.

Shuwen Fu (S)

Department of Pathobiology, Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Yongxiang Wang (Y)

Department of Pathobiology, Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Jisu Li (J)

Liver Research Center, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, RI, USA.

Shuping Tong (S)

Department of Pathobiology, Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China; Liver Research Center, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, RI, USA. Electronic address: shuping_tong_md@brown.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH